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Xunxian LiuAbstract
Aging is linked to decrease of the body cell use of growth hormone (GH) and thyroxine, whereas the decrease is
via “death hormones” inhibition? This study proposes different viewpoints. Since interleukin 17 receptor C (IL17RC)
is highly expressed in tissues from age-related macular degeneration (AMD) patients, IL17RC signaling pathways are
explored to evaluate Wnts/vascular endothelial growth factor (VEGF) expression and complement activity, which are
pathological factors in AMD. IL17RC overexpression or VEGF treatment was performed in two cell lines for up to
two-day. Real-time Quantitative PCR, confocal microscopy, immune-blot, MTT assay, etc. measured downstream
effects. IL17RC overexpression increases Wnts and VEGF that forms complexes with Wnt-signaling components.
VEGF or the Wnt-signaling components interacting with C3 suggests alternative complement pathway activation.
Moreover, IL17RC-overexpressed cells or VEGF-treated cells for two-day, which is overstimulation, increase
PI3K/Akt/GSK3 insensitivity and GSK3 activity, and decrease growth/survival. High GSK3 activity associates with many
chronic diseases including type II Diabetes. This study shows high GSK3 activity can result from PI3K/Akt
overstimulation. Type II Diabetes shows insulin resistance that the body cells decrease insulin use. Possessing little
sensitive PI3K/Akt for receptor activation, cells after overstimulation, although live, hardly respond to PI3K/Akt
activators including GH, thyroxine and insulin. These results suggest an alternative explanation of the body cells
declining hormone use since various kinds of cell signaling-induced overstimulation events almost always linked to
PI3K/Akt, increase with age. Playing pathological roles in senescence and diseases, overstimulation eventually
generates health problems.
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In 1974, Dr. W. Donner Denckla proposed Death Hormone
or DECO (decreasing oxygen consumption hormone)
Theory (Denckla 1974). Regularly released by the human
pituitary gland, DECO suppresses the ability of cells to use
thyroxine (Denckla 1974), which causes people to age. The
principal functions of thyroxine are to stimulate oxygen
consumption and control metabolism of all cells and tissues
in the body (Welcker et al. 2013). Age-related decrease in
use of growth hormone (GH) by body cells has also been
found (Blackman et al. 2002). However, the deathCorrespondence: xunxianl@mail.nih.gov
Intramural Research Program, National Center for Complementary and
Alternative Medicine, National Institutes of Health, US Department of Health
and Human Services, Bethesda, MD 20892, USA
© 2014 Liu; licensee Springer. This is an Open
License (http://creativecommons.org/licenses/b
medium, provided the original work is properlyhormones are nonetheless unidentified. Because of high
expression of IL17RC in peripheral blood and chorioret-
inal tissues with AMD lesions increases age-related macu-
lar degeneration (AMD) risk (Wei et al. 2012), exploration
of IL17RC signaling pathways sheds light on possible mo-
lecular biology mechanisms that reduce the use of the
relevant hormones in the body cells. These mechanisms
lead to an alternative proposal of the Death Hormone
Theory.
AMD is the leading cause of irreversible blindness in
the elderly population worldwide. The disease causes
progressive loss of central vision because of macular
geographic atrophy (GA) (dry AMD) or choroidal neovas-
cularization (CNV) (wet AMD) (Sunness 2006). AMD is
associated with many factors. A recent study shows thatAccess article distributed under the terms of the Creative Commons Attribution
y/4.0), which permits unrestricted use, distribution, and reproduction in any
credited.
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tected on the surface of peripheral blood cells from AMD
patients (Wei et al. 2012). How high expression of IL17RC
increases AMD risk, which is investigated in the study, is
unknown. High expression of IL17RC is also detected in
the chorioretinal tissues containing AMD lesions (Wei
et al. 2012), whereas GA or CNV of the retinal pigment
epithelium (RPE) results in RPE cell death in the two
forms of advanced AMD (Sunness 2006). Therefore, in
the study, the experiments were performed using cultured
cells: ATCC retinal pigment epithelium (ARPE) and the
culture of monocytes (THP-1) without or with high
expression of IL17RC. This research suggests that the
etiology of AMD associated with high expression of
IL17RC (Wei et al. 2012) is attributed to two pathways: in-
creased complement and GSK3 activities that cause cell
death. Although the original objective was to find how
high expression of IL17RC increases AMD risk, this study
had three findings in general cell signaling: 1. overstimula-
tion causes insensitivity of PI3K/Akt/GSK3 that is asso-
ciated with almost any cell signaling; 2. releases GSK3
activity; and 3. can be created by PI3K/Akt activators.
These findings are the basis for an alternative explanation
of declined use of the hormones in the body cells.
Materials and methods
Cells and transfection
ARPE (RPE from ATCC) and THP-1 cultured monocytes)
were obtained from ATCC, and the cells were cultured ac-
cording to the protocols from ATCC. Transfection (2 μg
of empty vector (EV) or 2 μg of IL17RC) was performed
using Nucleofector II purchased from Lonza according to
the protocols from the manufacturer.
Antibodies and reagents
Anti (α)-Akt, α-pAkt, α-Axin, α-β-catenin, α-C3, α-c-
Myc, α-cyclin D1, α-GSK3, α-GSK3β, α-pGSK3, α-IL17,
α-IL17RC, α-IRS1, α-PI3K, α-pPI3K, α-TAU, α-VEGF,
α-Wnt-3a, and α-Wnt-10b were purchased from Santa
Cruz. α-c/EBPα, α-pc/EBPα, α-ERK1/2, α-pERK1/2, and
α-pIRS1 were bought from Cell Signaling Technology.
α-GSK3β was obtained from BD Transduction Lab.
GAPDH was purchased from ImmunoChemical. IL17A,
IL17F and sFRP2 were bought from R and D. VEGF was
obtained from Sigma-Aldrich. IL17A or IL17F (500 ng/mL),
sFRP2 (250 ng/mL) or VEGF (10 ng/mL) was applied to
cell culture. An IL17RC expression vector was purchased
from OriGene.
Confocal microscopy analysis
EV- or IL17RC-transfected ARPE cells were plated onto
sterile cover slips. Cells were left untreated or treated with
sFRP2 for two-day. The fixing, blocking and staining pro-
cedures have been described (Liu et al. 2011), but thebuffers did not contain any detergent. Samples were
stained with primary rabbit antibodies 1:50 (α-IL17RC for
Figure 1A, α-β-catenin for Figures 2 and 3A, α-VEGF for
Figure 2, the bottom panel and Figure 3C, α-GSK3β
for Figure 3B) and primary mouse antibodies (α-VEGF for
Figure 2, the top panel, α-GSK3β for Figure 2, α-C3 for
Figures 3A-C), as well as secondary antibodies goat anti-
rabbit conjugated FITC 1:100 for Figure 1A or donkey/
goat anti-rabbit conjugated rhodamine 1:100 combining
with goat anti-mouse IgG1 conjugated FITC at 1:100 for
Figures 2 and 3. The secondary antibodies were purchased
from Santa Cruz. VECTA-SHIELD HardSet Mounted
Medium with DAPI (Vector Labs) was employed for
mounting cover slips. Cells were viewed with a confocal
laser microscope (Lenses: 63 W;LSM510; Carl Zeiss
MicroImaging, Inc.) in the Lab of Cellular and Develop-
mental Biology, NIDDK, NIH.
Western blot analysis
Cultured cells were lysed with lysis buffer from Cell Sig-
naling Technology, and lysates were cleared at 3000 rpm
and 4°C or treated ARPE was lysed with a buffer con-
taining a low concentration of detergent for detection of
β-catenin (Figure 1D). The buffer and the procedure for
preparation of lysates with a low concentration of de-
tergent have been described in (Liu et al. 2011). Protein
concentrations were assessed in the cell lysates using
bicinchoninic acid protein (BCA) assay kit (Thermo Scien-
tific). Western blotting procedures have been described (Liu
et al. 2011; Liu et al. 2005). Densitometer to scan Western
blot bands was NIH Image J.
Real-time quantitative PCR (RT-PCR) analysis
EV- or IL17RC-transfected ARPE cells were plated 2000
cells/well in a 96-well plate or 20000 cells/well in a
24-well plate. Cells were left untreated or treated with
IL17A or IL17F for two days. Power SYBR Green Cell to
CT Kit (Applied Biosystems) was directly applied to cells
in the 96-well plates according to the protocol from the
manufacturer to generate RT-PCR results, or RNA was
extracted from cells in 24-well plates using a Qiagen kit.
Primers to amplify VEGF, Wnt-3a, Wnt-10 and RPLP0 are
described as follows: VEGF forward 5′ctacctccaccatgccaagt,
reverse 5′tggtgatgttggactcctca; Wnt-3a forward 5′caaga
ttggcatccaggagt, reverse 5′atgagcgtgtcactgcaaag; Wnt-10b
forward 5′tgctttttccttctccatgc, reverse 5′tccaagaaatcccga
gagaa; RPLP0 forward 5′ ggcgacctggaagtccaact, reverse
5′ ccatcagcaccacagccttc. RT-PCR procedures from total
RNA have been described (Liu et al. 2011). Each value of
mRNAs was averaged from means, determined by three to
six replicates and normalized by RPLP0 mRNA values in
three or more separate experiments. Gene expression in
untreated EV-transfected cells was used as a control to
compare with that in cells with any other treatment.
Figure 1 IL17RC induces VEGF and Wnts. A. Confocal microscopy procedures were applied to EV- or IL17RC-transfected ARPE. Images are indicated
in the figure and an example spot is indicated by arrows. DAPI is the intensity control and phase shows cell-surface. B. EV- or IL17RC- transfected ARPE cells
were treated as indicated. Cell lysates were immune-blotted with indicated antibodies. C. RT-PCR of VEGF, Wnt-3a and Wnt-10b. EV- or IL17RC- transfected
ARPE cells were treated as indicated. Values of mRNA from EV are set as one. Data are averaged from three or more separate experiments and represented
as mean ± SD. *, ** or *** versus EV of the cognate groups: p < 0.05, 0.01 or 0.001. D. EV- or IL17RC- transfected ARPE cells were treated as indicated. Cell
lysates were immune-blotted with indicated antibodies. LD: low concentration of detergent. In B and D, GAPDH is the loading control. For A, B and D, data
represent three or more separate experiments. Statistic details of the blots in B or D are shown in Additional file 1: Figure S1A or B.
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MTTassay kit was purchased from Promega, and the assay
was performed according to the manufacturer protocol. For
Figure 4C, MTT assay of 8 or more replicates (EV- or
IL17RC-transfected cells) was performed. The values were
measured at day 0. Two days later, MTT assay of 10 or
more replicates (EV-transfected cells or IL17RC-transfected
cells treated without or with sFRP2) was performed. The
values of day 2 divide those of day 0 in the cognate groups.
The ratios from EV groups are set as one. For Figure 5C,
values of each time point were determined by 8 or more
replicates and the value at 0 h was set as one.
Statistical analysis
All shown data represent three or more experiments.
Quantitative data are presented as mean values ± SD,
averaged from three or more separate experiments. The
statistical analysis was performed using the JMP (SAS
Institute) statistical package based on t-test. An adjusted
P-value of < 0.05 was considered significant.
Results
IL17RC overexpression increases expression of canonical
Wnts and Wnt-downstream target gene and proteins in
ARPE
Because high expression of IL17RC protein in peripheral
blood and chorioretinal tissues with AMD lesions (Weiet al. 2012), transfection of IL17RC in cultured cells was
performed to achieve high IL17RC expression. EV or
IL17RC was transfected into ARPE for two-day. IL17RC
was partly expressed on the cell surface as an example
spot that was stained green in the green image and that
topped the cell surface in the phase image as indicated by
the arrows. The green spot superimposes the phase spot
in the merge image (Figure 1A). IL17RC-overexpressed
ARPE had higher expression of IL17RC using confocal
microscopy because these cells were stained greener
(Figure 1A). Since Wnt-signaling plays pathogenic roles in
AMD in a mouse model and Wnt-3a induces vascular
endothelial growth factor (VEGF) in ARPE (Zhou et al.
2010), protein levels of IL17RC and VEGF as well as
mRNA levels of VEGF and Wnts in ARPE were examined.
More protein expression (2 or more folds) of IL17RC and
VEGF as well as more mRNA expression (2 or more folds)
of VEGF, Wnt-3a and Wnt-10b were detected in IL17A or
IL17F-treated and/or IL17RC-transfected ARPE than
those in EV-transfected ARPE. However, IL17A or IL17F
did not further increase the protein and/or gene ex-
pression levels in IL17-RC transfected ARPE (Figures 1B
and C), probably due to the system saturation in the same
pathway or insensitivity to long strong stimuli (see below)
such as overexpression of IL17RC and/or treatment of
IL17A or IL17F in ARPE for two-day. Because Wnts were
induced by IL17RC overexpression, Wnt-signaling was
Figure 2 IL17RC overexpression increases colocalization of VEGF/β-catenin and VEGF/GSK3β. Confocal microscopy procedures were applied
to EV-transfected ARPE or IL17RC-transfected ARPE treated without or with sFRP2. Images were indicated in the figures. DAPI is the intensity control.
Data represent three separate experiments.
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Wnt-3a and Wnt-10b, Wnt-target genes or stabilized pro-
tein (VEGF (Zhang et al. 2001) (> 2-fold increase), c-Myc
(He et al. 1998) (> 2-fold increase), cyclin D1 (Tetsu and
McCormick 1999) (> 20% increase), and β-catenin (Liu
et al. 2005) (> 2-fold increase) was detected in IL17RC-
overexpressed ARPE than that in EV-transfected ARPE,
whereas secreted frizzled-related protein 2 (sFRP2) abol-
ished most of the induction levels in comparison to the
levels of those proteins in IL17RC-transfected ARPE
(Figure 1D). sFRPs act as soluble inhibitors of Wnt sig-
naling (Rattner et al. 1997) and sFRP2 did not decrease
IL17RC overexpression (Figure 1D). Despite expectation
of higher levels of Wnt-3a and Wnt-10b, the lowest levels
of those were detected in IL17RC-overexpressed and
sFRP2-treated ARPE (Figures 1D) perhaps because, when
associated with sFRP2 in media, Wnts could no longer
be bound to their receptors on the cell surface or be de-
tected by immune-blots. Interestingly, protein levels of
IL17RC were increased by treatment of IL17A or IL17F
(Figure 1B), whereas endogenous IL17 was also increased
by overexpression of IL17RC (Figure 1D). These data sug-
gest the cognate ligand/receptor interactions, resulting in
decrease of the protein degradation. This hypothesis ispartly supported by IL17-increased gene expression of
IL-17RA but not IL17RC (Venkatachalam et al. 2008).
IL17RC overexpression increases interactions of
VEGF/β-catenin and VEGF/GSK3β in ARPE
Although VEGF gene and protein expression was in-
creased in IL17RC-transfected ARPE (Figures 1B and C),
VEGF interaction with Wnt-signaling components for
contribution to increased VEGF protein expression in
IL17RC-transfected ARPE (Figure 1D) was sought. Con-
focal microscopy detected more pure yellow fluores-
cence in the merge images from IL17RC-transfected
ARPE than in those images from EV-transfected ARPE,
showing that co-localization of VEGF/β-catenin and
VEGF/GSK3β is increased but that the increased levels
were abrogated by sFRP2 treatment (Figure 2). There-
fore, Figure 2 suggests that higher interactions of VEGF/
β-catenin and VEGF/GSK3β contribute to higher protein
expression of VEGF in IL17RC-overexpressed ARPE.
IL17RC overexpression increases alternative complement
pathway in ARPE
Since VEGF or β-catenin can be located outside cells or
in plasma membrane, whether β-catenin, GSK3β or
Figure 3 IL17RC overexpression increases complexes of C3/β-Catenin, C3/GSK3β or C3/VEGF. In A to C, confocal microscopy procedures
were applied to EV-transfected ARPE or IL17RC-transfected ARPE treated without or with sFRP2. Images and treatments are labeled in the figures,
big C3 complexes are indicated by arrows, and damaged cells are red-framed. DAPI is the intensity control and phase shows cell-surface. Data
represent three separate experiments.
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that the interactions of VEGF/β-catenin and VEGF/
GSK3β (Figure 2) are aberrant and possible on the cell
surface. These interactions were also accompanied with
higher levels of the protein expression, such as β-catenin
and VEGF (Figure 1), whereas higher protein expression
augments possibility to produce abnormal proteins.Complement also plays the pathogenic role in AMD
(Zipfel et al. 2010). Alternative complement pathway was
investigated since it is activated by foreign antigens/
abnormal proteins on the cell surface (Abbas et al. 2010),
whereas activation of classical complement pathway re-
quires antibodies (Abbas et al. 2010) and it is impossible
to generate antibodies in vitro and in two-day. The first
Figure 4 IL17RC induces insensitivity of PI3K, Akt or GSK3. EV-transfected ARPE (A) or THP-1 (B) or IL17RC-transfected ARPE (A) or THP-1 (B)
treated without or with sFRP2, cell lysates were immune-blotted with indicated antibodies. In A, GAPDH is the loading control; data represent three or
more separate experiments. C. MTT assay of EV-transfected cells or IL17RC- transfected ARPE or THP-1 cells treated without or with sFRP2.
Data are averaged from three or more separate experiments and represented as mean ± SD. * or ** versus EV in the cognate groups: p < 0.05 or 0.01.
Statistic details of the blots in A or B are shown in Additional file 1: Figure S1C or Additional file 2: Figure S2A.
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by foreign antigens/abnormal proteins is C3 (Abbas et al.
2010). Confocal microscopy detected C3 (green) co-
localized with β-catenin, GSK3β or VEGF (all are red) in
distinct compartments (Figure 3). Big green or yellow spots
are indicated by red arrows in green or merge images
(Figures 3A-C). Those spots are considered to be C3 com-
plexes because: 1) they are outside cells; 2) some of the
spots are located on damaged cells with distorted nuclei
(DAPI, blue) or cell shapes, suggesting that the complexes
are cell killers. However, most of the spots were located on
intact cells since C3-activated complements-pathway is
inhibited by complement factor H/I (Abbas et al. 2010) or
the complement complex to destroy cells might be in early
stages. Small green spots are not counted as they might be
inactivated C3 complexes or their complement reactions
might be incomplete. Moreover, damaged cells are in-
cluded by red frames. Often accompanied by bright C3
staining, those damaged cells include cells with distorted
or shrunken nuclei, distorted cell shapes, or cells without
nuclei. By either of the criteria, IL17RC overexpression
increased alternative complement pathway activity, com-
pared with that in EV-transfected ARPE (Figure 3). Despite
blocking IL17RC-induced Wnt-signaling and interactions
of VEGF/β-catenin and VEGF/GSK3β (Figures 1 and 2),
sFRP2 treatment did not reduce the complement activity,
compared with that in IL17RC-transfected ARPE (Figure 3),
perhaps because recombinant mouse sFRP2 is a foreign
protein for human ARPE. Nevertheless, the images showmost arrow-indicated spots in the merge images from
IL17RC-transfected cells because β-catenin, GSK3β or
VEGF was in the C3 complexes indicated by more or less
yellow fluorescence; however, comparable amounts of the
arrow-indicated spots are observed in the green images
from IL17RC-transfected and sFRP2-treated ARPE, which
shows that the C3 complexes (green spots) did not contain
β-catenin, GSK3β or VEGF. The framed damaged cells in
the images from IL17RC-transfected ARPE also show the
most co-localization of C3 with β-catenin, GSK3β or VEGF
(Figure 3). Figures 2 and 3 suggest that IL17RC-induced
Wnt-signaling and VEGF are involved in the activation of
complement.
IL17RC overexpression causes PI3K/Akt/GSK3 insensitivity
and cells death
As VEGF was increased in IL17RC-transfected ARPE
(Figure 1), and VEGF belongs to growth hormone family
in which a member generally activates extracellular signal-
regulated kinases (ERK1/2) and PI3K/Akt (Liu et al. 2011),
the signaling pathways were tested. Figure 4A and B
shows that phosphorylation of ERK1/2, especially ERK1,
was increased. However, tyrosine phosphorylation (Y208)
of PI3K50α (pYPI3K) (Accession#:NP_852665.1), one of
PI3K regulatory subunits, was surprisingly abrogated in
cells transfected with IL17RC for two-day. Contrasting
with the above statement (VEGF activating PI3K/Akt), the
observation suggests that PI3K is insensitive to persistently
high levels of VEGF and/or other PI3K stimuli. Since PI3K
Figure 5 VEGF induces insensitivity of Akt or GSK3. VEGF-treated ARPE (A) or THP-1 (B) cell lysates were immune-blotted with indicated antibodies;
GAPDH is the loading control; data represent three or more separate experiments. C. Results of MTT assay (growth/survival). Data are averaged from
three or more separate MTT assay experiments, and represented as mean ± SD. * or ** versus any other treatment: p < 0.05 or 0.01. Statistic details of
the blots in A or B are shown in Additional file 2: Figure S2B and C or Additional file 3: Figure S3A and B.
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Kinase Akt Signaling, Cell Signaling Technology), inactiva-
tion of PI3K decreased Akt activity because of decreased
detection of threonine phosphorylation (T308) (pSAkt),
leading to increase of GSK3 activity due to lower levels of
serine phosphorylation (S21 and S9) (pSGSK3) in IL17RC-
transfected cells (Figure 4A). Consequently, phosphoryla-
tion levels of GSK3 substrates, CCAAT-enhancer-binding
protein α (Ross et al. 1999), (pcEBPα), Insulin receptor
substrate 1 (pIRS1) (Liberman and Eldar-Finkelman 2005),
and Tau protein (pTAU) (Hanger et al. 1992) increased,
compared with those in cells transfected with empty vec-
tor (EV); sFRP2 treatment abolished the effects induced by
IL17RC transfection (Figure 4A). Immune-blots of all the
total proteins, in addition to measurement of levels of the
phosphorylation proteins, were also performed (Figure 4A).
These data show higher GSK3 activity in ARPE transfected
with IL17RC for two-day. However, β-catenin is also a
GSK3 substrate (Ikeda et al. 1998) but may not be a Wnt-
target gene as there is no such report, and it is still sta-
bilized (Figure 1D) in the environment with high GSK3
activity, probably due to Wnt-induced Axin degradation(Figure 4A). GSK3 phosphorylating β-catenin requires
Axin (Liu et al. 2002; Amit et al. 2002).
Similar results were observed in IL17RC-transfected
THP-1. After cells were transfected with IL17RC for
two-day, Wnt-3a, Wnt-10b and VEGF were increased
(Figure 4B). In contrast with the insensitivity target, PI3K
in ARPE (Figure 4A), the insensitivity targets to the
regulation were identified to be Akt and GSK3 in IL17RC-
transfected THP-1 because the level of pYPI3K was
increased, whereas the level of pSAkt was unchanged, and
the levels of pSGSK3 were lowest in comparison to those
in EV-transfected cells and IL17RC-transfected plus
sFRP2-treated cells (Figure 4B). Nevertheless, the patterns
of phosphorylation levels of GSK3 substrates in THP-1
cells were similar to those in ARPE cells (Figures 4A
and B).
GSK3 participates in various apoptotic signaling path-
ways by phosphorylating transcription factors regulating
apoptosis (Jope and Johnson 2004); GSK3 promotes apop-
tosis by both activating pro-apoptosis factors such as p53
(Watcharasit et al. 2002) and inactivating survival-promo-
ting factors through phosphorylation (Grimes and Jope
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tested. MTT assays show that overexpression of IL17RC
decreased cell growth/ survival in ARPE (p < 0.05) and
THP-1(p < 0.01) (Figure 4C), which is consistent with that
high GSK3 activity induces cell apoptosis (Jope and
Johnson 2004; Watcharasit et al. 2002; Grimes and Jope
2001). Despite insignificant rescues, sFRP2 treatment de-
creased a little death in IL17RC-overexpressed ARPE and
more death in IL17RC-overexpressed THP-1 because the
sFRP2 is a foreign protein for human cells and can activate
complement alternative pathway (Figure 3). Additionally,
the GSK3 insensitivity percentages, (100% pSGSK3αβ
levels in EV-transfected cells) - % of pSGSK3αβ levels in
IL17RC-transfected cells) (Additional file 1: Figure S1C
and Additional file 2: Figure S2A), were about 56% in
ARPE and 44% in THP-1, compared with those in-
sensitivity percentages (set as 0%) of the cognate cells
transfected with EV. Therefore, IL17RC overexpression
causes more than 50% of damage in these cells by de-
creasing growth/ survival and increasing GSK3 insensiti-
vity by adding the percentages of growth/survival decrease
(Figure 4C) and GSK3 insensitivity that was rescued by
sFRP2 treatment (Additional file 1: Figure S1C, Additional
file 2: Figure S2A).
VEGF causes Akt/GSK3 insensitivity and cells death
To further investigate the concept that PI3K/Akt/GSK3
insensitivity to regulation can be induced in cells by long
treatment of VEGF alone, cells were merely adminis-
trated with VEGF to eliminate the complex of stimuli as
IL17RC signaling and/or Wnt-signaling induce expres-
sion of a number of genes that may result in other PI3K
stimulators in addition to VEGF. Kinetics of pYPI3K,
pSAkt, pSGSK3 and phosphorylation of GSK3 substrates
as well as growth/survival in ARPE or THP-1 was tested.
Cells were treated with VEGF at 0, 0.5, 1, 16, 24 and
48 h. Treated cell lysates were collected for Western
blots, or the treated cells were applied to MTT assays.
Figure 5A shows that the insensitivity target proteins to
the regulation were identified to be GSK3 because the
levels of pYPI3K and pSAkt were elevated, whereas the
levels of pGSK3 were significantly reduced at the later
time points. Moreover, phosphorylation levels of GSK3-
target substrates were suggested to have increased as the
protein expression levels of c-Myc and cyclin D1 were
decreased, whereas the levels of pIRS1 and pTAU were
increased at later time points in ARPE (Figure 5A).
Figure 5B shows that the upstream insensitivity target
protein to the regulation was Akt as the levels of pYPI3K
consistently increased in comparison to those at time 0.
However, the levels of pSAkt significantly increased at
1 h (p < 0.05) and 16 h (p < 0.01) (Additional file 3:
Figure S3C) compared to those at 0 h, whereas those
levels were decreased at later time points (Figure 5B).GSK3 insensitivity to Akt regulation was also observed
because of the highest level of pSGSK3 at time 0
(Figure 5B and Additional file 3: Figure S3C). Similar
phosphorylation patterns of GSK3 substrates in THP-1
to those in ARPE were detected (Figures 5A and B). In
both systems, there was no additional Wnt-signaling so
that the degradation of c-Myc and cyclin D1 was appa-
rently detectable further verifying that GSK3 activity was
increased by read-out from the GSK3-target substrates
at the later time points (Figures 5A and B). MTT assays
show that growth/survival in ARPE was decreased at the
later time points (1 h to 48 h) (p < 0.05). The maximum
values of growth/survival and pGSK3 which was the
insensitivity target in VEGF-treated ARPE were detected
at around 0.5 h (Figures 5A and C). Although MTT as-
says show that growth/survival in THP-1 did not sig-
nificantly decrease at 48 h compared with that at 0 h,
the growth/survival significantly increased at 1 h
compared to that of any other time point (Figure 5C)
(p < 0.01). The maximum values of growth/survival and
pAkt which was the insensitivity target in VEGF-treated
THP-1, were detected at approximately 1 h (Figures 5B
and C). Hence, the results suggest that growth/survival
is determined by the upstream insensitivity target in cells
treated with VEGF for a while. The GSK3 insensitivity
percentages (100% (pSGSK3αβ levels at 0 h) - % of
pSGSK3αβ levels at 48 h) (Figure 5A and B) are over
50% in ARPE or over 70% in THP-1. Including the per-
centages of growth/survival reduction and GSK3 insensi-
tivity, more than 70% of damage in ARPE or THP-1 was
caused by VEGF treatment for 48 h (Figure 5).
Discussion
In this study, the evidence suggests that IL17RC increases
AMD risk via two pathways, alternative complement
pathway and insensitivity of PI3K/Akt/GSK3 (delinked
regulation by stimuli) resulting in increased GSK3 activity
(Figure 6). Both pathways can be induced by IL17RC-
increased Wnt-signaling and VEGF, whereas sFRP2 blocks
IL17RC-induced insensitivity due to its inhibitory effects
on Wnt-signaling (Figures 1, 4 and 6). Since high levels of
IL17RC are detected in chorioretinal tissues with AMD le-
sions (Wei et al. 2012), this study shows that high IL17RC
expression increases complement and GSK3 activities,
resulting in less cell growth/survival (Figures 3 and 4).
Moreover, Th17 cells are essential in clearing pathogens
during host defense and in inducing inflammation during
autoimmune disease (Korn et al. 2009). Elevated levels of
IL17A are found in AMD patients’ serum and macular tis-
sues and high IL17RC levels are detected in CD14+ mono-
cytes from AMD patients, whereas high levels of IL17
increases IL17RC and vice versa (Figure 1), and high
IL17RC levels increase GSK3 activity in cells (Figure 4);
therefore, living in the same environment as CD14+
Figure 6 Potential pathways tested or stated in the study lead to diseases including AMD. Details of the pathways are depicted in the text.
sFRP2 (RM): recombinant mouse sFRP2. Red arrows and blocks: provided that the stimuli are overstimulation of PI3K/Akt, which is the improvement of
the doctrine. The numbers 1, 2, 3 in the block lines represent insensitivity stages 1(GSK3 insensitivity), 2 (Akt insensitivity), 3 (PI3K insensitivity). PI3K/
pSAkt/pSGSK3 is put into the red frame. The black arrows between VEGF and PI3K, and stimuli and receptors indicate stimulation without causing
insensitivity or high GSK3 activity.
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have higher levels of GSK3 activity, resulting in apoptosis
(Jope and Johnson 2004; Watcharasit et al. 2002; Grimes
and Jope 2001), and to produce more inactive proteins by
GSK3 phosphorylation. These proteins, such as trans-
cription activators (Jope and Johnson 2004), survival-
promoting factors (Jope and Johnson 2004; Grimes and
Jope 2001) and IRS1 (Liberman and Eldar-Finkelman
2005), are required for normal cell functions. Hence, high
IL17RC expression in eye and peripheral blood cells (Wei
et al. 2012) increases rate of cell death and decreases rate
of debris clean in eye cells, leading first to accumulation
of drusen in macula and then to AMD. This research
reveals relationships (Figure 6) among IL17RC, Wnt-sig-
naling/VEGF and complement, which have been thought
or treated as separate factors playing roles in AMD path-
ology in previous studies (Wei et al. 2012; Zhou et al.
2010; Zipfel et al. 2010); in addition, it is the first time that
GSK3 is suggested to play pathological roles in AMD
(Figure 6).
Because GSK3 is constitutively activated (Biondi and
Nebreda 2003), maintenance of PI3K/Akt activity is re-
quired for GSK3 inhibition and human health. GSK3 is
connected to outside environment of the cell via PI3K/
Akt as PI3K is activated by many various types of cell re-
ceptor signaling (PI3 Kinase Akt Signaling, Cell SignalingTechnology), which are modulated by alteration of en-
vironmental and/or genetic factors (Figure 6). The data
indicate that overstimulation of receptors results in in-
sensitivity of the pathway (PI3K/Akt/GSK3), and increase
of GSK3 activity, not tallying with a doctrine: a stimulus
activates PI3K, PI3K activates Akt and Akt represses
GSK3 activity. A clinical example shows that people
treated with hormones including GH belonging to GH
family that activates PI3K/Akt (Liu et al. 2011) also
increase adverse effects, such as diabetes and glucose
intolerance (Blackman et al. 2002), which can be
expounded by possible high GSK3 activity in those people
after a certain period of the hormone administration.
Decreasing usage of ligands, such as thyroxine (Denckla
1974) that activates Akt (Kuzman et al. 2005), also leads
to less activated PI3K/Akt and higher GSK3 activity in
cells. Therefore, through any of the following ways: over-
stimulation of PI3K/Akt, reduction of using native PI3K/
Akt stimuli or inhibition of PI3K/Akt, release of GSK3 ac-
tivity eventually and always happens (Figure 6). A stimulus
exists persistently, such as high IL17RC expression in eye
and peripheral blood cells in AMD patients (Wei et al.
2012), or is repeatedly administrated, such as GH
(Blackman et al. 2002), leading to overstimulation of
PI3K/Akt. Then, the cell response system to any stimuli
associated with the pathway will be broken, and the cells
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pGSK3α undulate in VEGF-treated ARPE (Figure 5A),
whereas a more severe damage of PI3K/Akt/GSK3 sensi-
tivity by IL17RC transfection in ARPE, the same cell line
(Figure 4A) suggests the latter overstimulation is stronger.
Of the four overstimulation results, the data indicate the
sequence of overstimulation-caused insensitivity: GSK3
insensitivity happens first, then Akt insensitivity, and
finally PI3K insensitivity (Figures 4A, B and 5A, B and 6).
Even if cells treated withVEGF in shorter terms (Figures 5A,
B and 6), GSK3 insensitivity still first occurs. There are
three overstimulation stages showing the insensitivity of
the kinases, presented by their activities. Stage1: high
GSK3, Akt and PI3K activities coincide (Figures 5A
and B); stage 2: high GSK3, low Akt and high PI3K acti-
vities concur (Figures 4B and 5A, B); stage 3: high GSK3,
low Akt and PI3K activities coexist (Figure 4A). Those
phenomena are summarized in Figure 6. On the other
hand, overstimulation-caused damage by the same me-
thod shows different degrees in different cell lines
(Figures 4A and B), probably due to different expression
levels of the related-proteins in the cell lines. Most over-
stimulated cells live as only about 15-25% decrease in
growth/survival is detected, whereas the insensitive GSK3
levels are about 40-70% in the cells with IL17RC overex-
pression or VEGF treatment (Figures 4 and 5). However,
the overstimulation does not affect ERK1 signaling, Wnt-
signaling-induced expression of c-Myc and cyclin D1,
and/or β-catenin and VEGF (Figures 1, 4 and 6) so that
the sensitivity of PI3K/Akt/GSK3 is vulnerable and dif-
ferent types of signaling are unsynchronized. ERK acti-
vation is dependent on PI3K/Akt by short stimulation
(Venkatachalam et al. 2008), whereas it is intriguing that
ERK activation is associated with high GSK3 activity du-
ring overstimulation stages when PI3K/Akt activities are
abolished or reduced (Figure 4A). Treated with androgen
and LY compound, a PI3K inhibitor for three-day, cells in
which GSK3 activity is suggested to increase because of
suppressed Akt activation dramatically augment ERK acti-
vation (Liu et al. 2011). Producing cells that scarcely re-
spond to stimuli, overstimulation is suggested to be the
fountainhead of the decreased use of hormones by the
body cells. In this regard, any PI3K/Akt activators, which
are unnecessary from the pituitary gland (Denckla 1974)
and can be inorganic molecules, organic molecules or
large molecules, can become death hormones as long as
they overstimulate PI3K/Akt in the body cells. Moreover,
according to the data, the alternative death hormone ex-
planation suggests that the inhibition of the body cells
using thyroxine and GH is due to past damage of PI3K/
Akt/GSK3 sensitivity but not due to present suppression
of the cell ability using the hormones (Denckla 1974).
Although many human cells sooner or later undergo
normal apoptosis, and new cells will replace the apoptoticcells by the body regeneration functions (Carlson 2007),
overstimulation-consequent high GSK3 activity-induced
apoptosis, which is abnormal death, decreases cell growth/
survival (Figures 4 and 5); moreover, high GSK3 activity
damages cell functions in ways such as inactivating
survival-promoting factors (Grimes and Jope 2001) and
IRS1 (Figures 4 and 5); furthermore, overstimulation
causes PI3K/Akt to be insensitive to environment stimuli
(Figures 4 and 5), suggesting that overstimulation creates
problems in many life processes including renewal of the
body cells. In addition, the regeneration functions decrease
with age; for instance, diminished epidermal cell prolifera-
tion is age-related (Grove and Kligman 1983). Hence, one’s
health situation will become worse and worse since
overstimulation events-caused insensitivity cells increase,
whereas the body’s self-renewal ability to replace the in-
sensitivity cells decreases, with age. On the other hand, the
data suggest that high levels of some activators remain in
the body cells. IL17RC increases IL17 expression and vice
versa (Figures 1 and 6), suggesting that high expression of
IL17RC is transferable between cells, especially from old
cells to new cells with normal IL17RC expression via high
concentrations of IL17 in the tissue environments (Wei
et al. 2012). IL17 is also a PI3K activator (Chen et al.
2011). That is perhaps one of reasons why AMD is
irreversible because high levels of IL17 and IL17RC
which generate insensitivity kinases still exist despite cell
replacement.
Accumulation of the insensitivity kinases in different
tissues/organs is also unsynchronized since overstimula-
tion is unevenly distributed and abilities for renewal of the
body cells in different tissues/organs differ, illustrating
why aging of the body tissues/organs differs. Diseases may
start from local aging of the body tissues/organs. In-
flammation is a common past or current symptom and
associates with many seemingly unrelated chronic diseases
(Ferrero-Miliani et al. 2007). Inflammation is caused by
proinflammatory cytokine, which is the name used to
describe a diverse group of soluble proteins, peptides, and
glycoproteins that act as hormonal regulators or signaling
molecules at nano- to-picomolar concentrations and help
in cell signaling (Gilman et al. 2001). Inflammation is as-
sociated with high GSK3 activity (Jope et al. 2007). This
study demonstrates that overstimulation increases GSK3
activity and suggests that high levels of proinflammatory
cytokine causing inflammation linked with high GSK3 ac-
tivity, one of the overstimulation consequences. Therefore,
high levels of proinflammatory cytokine including IL17
(Venkatachalam et al. 2008) are likely to cause overstimu-
lation in the body cells, and inflammation is an additional
consequence of overstimulation. IL17 stimulating inflam-
matory response requires IL17RC (Venkatachalam et al.
2008). Overexpression of IL17RC also associates with in-
flammation, such as ocular sarcoidosis (Wu et al. 2014).
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Diabetes and Alzheimer’s disease (Wagman and Nuss
2001), whereas type II Diabetes is associated with AMD
(Topouzis et al. 2009), and blinding AMD may be asso-
ciated with cognitive impairment (Baker et al. 2009). All
three diseases are associated with inflammation (Gilman
et al. 2001; Wang et al. 2011). In cultured cells transfected
with IL17RC or treated with VEGF , high levels of pIRS1,
associating with type II Diabetes and causing insulin re-
sistance (Liberman and Eldar-Finkelman 2005) (Figure 6)
in that the body cells reduce their use of insulin (Kumar
et al. 2005), and pTAU, associating with Alzheimer’s dis-
ease (Yang et al. 1999), have been detected (Figures 4 and
5). Increased PI3K/Akt/GSK3 insensitivity (Figure 6) can
also decrease using insulin, which is another explanation
of insulin resistance in addition to high levels of pIRS1,
since insulin is also a PI3K activator (Brown et al. 1999).
Logically, high levels of pIRS1 should appear after high
levels of GSK3 insensitivity and activity in an over-
stimulated cell. Additionally, GSK3β mediating high
glucose-induced ubiquitination and proteasome degrad-
ation of IRS1 enhances insulin resistance (Leng et al.
2010). Moreover, AMD doubles heart attack and stroke
risk (Tan et al. 2008). Immune cells with high GSK3 acti-
vity may also increase risk of cardiovascular diseases
(CVD) and cancer since the cells are suggested to be
apoptotic (Jope & Johnson 2004; Watcharasit et al. 2002;
Grimes and Jope 2001) or insensitive to PI3K/Akt stimuli
(Figures 4 and 6) or with impaired cell functions (24,
Figures 4 and 6); hence, these cells may have low capa-
bilities to eliminate LDL particles and cell debris from
blood vessels and to destroy abnormal cells. Whether high
GSK3 activity and/or inactivation of PI3K/Akt in peri-
pheral blood cells increase CVD or cancer risk or poor
outcome of cancer remains to be investigated.
The study first elucidates how GSK3 activity is released
and how cells become insensitive as well as die early,
explaining why the body cells reduce use of the hormones
with age (Denckla 1974; Blackman et al. 2002). Overstimu-
lation-caused PI3K/Akt/GSK3 insensitivity and high GSK3
activity are the fundamentals to propose the alternative
death hormones hypothesis. Now, the hypothesis not only
is a testable model but also provides a rationale to inter-
pret many clinical phenomena. Given that PI3K/Akt/
GSK3 expression is in ubiquity and that the pathway is
associated with almost any signaling, overstimulation-
induced insensitivity in this study can occur in any cell of
the body, which will in turn cause health problems.
Biological mechanisms of many factors including dis-
eases, genetic changes, habits, life styles, medical and
psychological effects, health products, physical exercise,
performance-enhancing drugs, obesity and/or hyperlip-
idemia, and hyperglycemia etc., are likely linked to the
pathway.Additional files
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